BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced additional preliminary findings from its Parkinson’s Disease (PD) Phase 2 trial showing that significantly more patients treated with the Company’s drug, NE3107, were assessed as being in the “ON” state in the morning after withholding their usual standard of care (SOC) for at least 8 hours before taking their usual morning Parkinson’s medications, compared to patients on SOC alone plus placebo (p<0.02).

American Resources Corporation’s (Nasdaq: AREC) American Carbon subsidiary, a leading producer of high quality metallurgical and specialty carbon, announced that it has commissioned its McCoy Elkhorn processing facilities in Pike County, Kentucky for internal processing, third party processing, and carbon loading businesses, thereby enabling additional growth opportunities and enhanced margins from existing production.

ASP Isotopes (Nasdaq: ASPI), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, announced that it has successfully concluded the construction and cold commissioning of its light isotope enrichment facility in Pretoria, South Africa. The Company achieved this milestone approximately three months faster than it originally anticipated.

Sidus Space (Nasdaq: SIDU), a Space-as-a-Service satellite company focused on commercial satellite design, manufacture, launch, and space-based data collection, was awarded a follow-on agreement for the next phase of NASA’s Autonomous Satellite Technology for Resilient Applications (ASTRA) project.